Carillion looks to sell its UK Healthcare arm

By Catherine Sturman
Construction giant Carillion has been struggling for some time, yet this is set to change. With losses of over £1 billion in just six months, the compa...

Construction giant Carillion has been struggling for some time, yet this is set to change. With losses of over £1 billion in just six months, the company has been rumoured to be selling off its UK healthcare business after increased interest from potential investors who view its long-term potential.

At present, the company is a leader in facilities management for the National Health Service, leading to a large number of proposals from potential investors. It has been stated that the company aims to receive over £300 million for a potential sale.

Related stories

“The Board of Carillion confirms that, consistent with Carillion’s announcement on 29 September 2017, it has received proposals from more than one credible counterparty for a possible acquisition of that business,” the company said.

“A further announcement will be made as and when appropriate.”

At present, the company is removing itself from all public-private partnership deals, but is continuing to work on the development of hospital facilities globally. However, staff shortages are responsible for ongoing delays to such construction works.

Share

Featured Articles

Oracle Fusion Cloud Update Boost for Patients

Oracle Fusion Cloud SCM includes new Healthcare Marketplace solution to help hospitals & clinics optimise planning, automate processes and improve outcomes

WHO Tightens air Quality Guidelines as Pollution Kills 7mn

World Health Organisation tightens air pollution guidelines to safeguard health; COVID prompts WHO to redefine 'air-borne' as it relates to diseases

WHO Health Chatbot Built on 'Humanised' GenAI

World Health Organisation's GenAI digital health tool is built using ‘AI humanisation’ tech & designed to ease burden on health workers & educate on health

Costco Weight-Loss Drugs Move Highlights US AOM Growth

Medical Devices & Pharma

AstraZeneca Company Profile, as CEO Soriot Lands pay Deal

Medical Devices & Pharma

US Academic Medical Centres 'Struggling' says McKinsey

Hospitals